Table 1 shows the timepoints when data were obtained from patients in the included studies
The semaglutide medication was FDA-approved for weight loss and weight management earlier this year
It also may be in response to, among other things, a letter sent to FDA on July 25, 2025 by a bi-partisan group of 81 legislators asking the FDA to respond to a surge in illegal and counterfeit anti-obesity medications (AOMs), which include semaglutide and tirzepatide, entering the United States from unregistered foreign entities. Going forward, compounders and other affected stakeholders must ensure that their API is sourced from FDA-approved manufacturers listed on the Green List and ensure compliance with Import Alert 66-80
Combination Therapy: Your provider may suggest a combination of medications to achieve the best results
For most goals, this range represents the best balance of effectiveness and tolerability
Incorrect Storage: Once reconstituted, BPC-157 must be stored in the refrigerator